Acetaminophen Injection, Solution
Product Images NDC 51662-1540

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Acetaminophen (NDC 51662-1540). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Boxed Information (Highlights)

A warning panel from the Acetaminophen Injection prescription drug label highlighting the risk of medication errors and hepatotoxicity. It advises caution regarding dosing in mg and mL, dosing based on patient weight under 50 kg, proper programming of infusion pumps, and adherence to maximum daily dose limits to avoid overdose and severe liver injury.*

FDA Label Image

Boxed Warning (Boxed)

A warning text panel describing risks of medication errors and hepatotoxicity associated with acetaminophen injection. It advises careful dosing in milligrams and milliliters, weight-based dosing for patients under 50 kg, proper programming of infusion pumps, and monitoring total daily dosage from all sources to prevent overdose and liver injury. The text highlights the potential for acute liver failure and death linked to excessive acetaminophen doses.*

FDA Label Image

T1 (Dosage T 1)

A dosing table for Acetaminophen injection solution detailing recommended doses for adults and adolescents 13 years and older, differentiated by weight (≥ 50 kg and < 50 kg). The table includes dose amounts given every 4 and 6 hours, maximum single dose, and maximum total daily dose for all administration routes.*

FDA Label Image

T2 (Dosage T 2)

A table titled 'Table 2. Dosing for Children' showing recommended acetaminophen dosing for children aged 2 to 12 years. It includes doses given every 4 hours (12.5 mg/kg), every 6 hours (15 mg/kg), maximum single dose (15 mg/kg up to 750 mg), and maximum total daily dose (75 mg/kg up to 3,750 mg).*

FDA Label Image

T3 (Dosage Table 3)

A table titled 'Dosing for Treatment of Fever in Neonates and Infants' showing acetaminophen dosing. It lists age groups (Neonates: birth to 28 days; Infants: 29 days to 2 years), the dose given every 6 hours (12.5 mg/kg for neonates, 15 mg/kg for infants), and the maximum total daily dose by all routes (50 mg/kg for neonates, 60 mg/kg for infants).*

FDA Label Image

Adverse (Adverse)

A data table showing treatment-emergent adverse reactions occurring in 3% or more of acetaminophen-treated adult patients versus placebo in repeated dose studies. It lists adverse reactions by system organ class and preferred term, with corresponding patient counts and percentages for acetaminophen (N=402) and placebo (N=379). Categories include gastrointestinal disorders, general disorders and administration site conditions, nervous system disorders, and psychiatric disorders.*

FDA Label Image

Structure (Structure)

Chemical structure of acetaminophen is shown, depicting its molecular arrangement including a benzene ring with hydroxyl (OH) and amide functional groups.*

FDA Label Image

Clinical P (Clinical Pharmacology)

A data table titled 'Acetaminophen Pharmacokinetic Parameters' displaying mean and standard deviation values for AUC 0-6h, C max, T 1/2, CL, and Vss across three subpopulations: Children, Adolescents, and Adults.*

FDA Label Image

Clinical S (Clinical Studies)

A line graph depicting mean temperature (°C) over time in hours post-dose, comparing IV acetaminophen with placebo. The vertical axis shows mean temperature from 38.0 to 40.0 °C, and the horizontal axis shows time from 0 to 6 hours. Two lines represent temperature changes, with IV acetaminophen showing a steady decrease over time compared to placebo.*

FDA Label Image

Vial Label (51662 1540 1)

A product label featuring a GS1 DataMatrix barcode and GS1 formatted text fields including a product code, expiration date, serial number, and batch code. The label includes a note to see the manufacturer's package insert and states the product is distributed by HF Acquisition Co., LLC, Mukilteo, WA 98275. This corresponds to Acetaminophen intravenous injection solution by HF Acquisition Co LLC.*

FDA Label Image

Vial Label (51662 1540 1 Vial Label)

Label for Acetaminophen Injection 1,000 mg per 100 mL (10 mg/mL) intravenous solution. The label includes dosage strength, usage instructions specifying 'For Intravenous Use Only,' and storage conditions. It lists HF Acquisition Co LLC, DBA HealthFirst as the labeler and contains the NDC 55150-307-01 barcode.*

FDA Label Image

Pouch Label (51662 1540 2 Pouch Label)

Label for ACETAMINOPHEN Injection 10 mg/mL in a 100 mL vial. The label shows the product name, concentration, vial size, NDC number 51662-1540-2, lot number, and expiration date. It is for intravenous use only, with additional handling and storage instructions. Manufactured by HF Acquisition Co LLC, Mukilteo, WA.*

FDA Label Image

Case Label (51662 1540 3 Case)

Packaging label for Acetaminophen Injection, 1000 mg per 100 mL (10 mg/mL) intravenous solution. The label indicates a 100 mL vial and a case quantity of 24. The product is manufactured by HF Acquisition Co LLC, DBA HealthFirst, with NDC 51662-1540.*

FDA Label Image

Rfid Label (51662 1540 3 Rfid Case)

Label on a package for ACETAMINOPHEN injection, 10 mg/mL, provided by HF Acquisition Co LLC, DBA HealthFirst. The label includes a machine-readable barcode, NDC-related numbers, batch or lot information, and states to see the manufacturer's insert. The label also indicates distribution by HF Acquisitions Co., LLC in Mukilteo, WA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.